Liability related to sale of future revenues, non-current
70,495
65,980
Other long-term liabilities
67
82
Long-term liabilities held for sale
-
0
Total liabilities
109,222
115,119
Redeemable non-controlling interests
21,480
21,480
Common stock, 0.01 par value 225,000 shares authorized at june 30, 2026 and december 31, 2025 4,049 and 4,047 shares issued and outstanding at june 30, 2026 and december 31, 2025
41
1,012
Additional paid-in capital
1,680,274
1,677,179
Accumulated other comprehensive loss
-1,188
-2,182
Accumulated deficit
-1,709,271
-1,706,047
Total stockholders' deficit attributable to kyntra bio
-30,144
-30,038
Nonredeemable non-controlling interests
520
13,033
Total deficit
-29,624
-17,005
Total liabilities, redeemable non-controlling interests and deficit
101,078
119,594
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.